UBS Group’s Synthorx, Inc. Common Stock THOR Stock Holding History

UBS Group’s Portfolio THOR Stock Details THOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-18,056	Closed	-$1.26M	–	8849
2019 Q4	$1.26M	Buy	18,056 +10,478	+138%	+$299K	﹤0.01%	3989
2019 Q3	$123K	Buy	7,578 +6,233	+463%	+$104K	﹤0.01%	5635
2019 Q2	$18K	Sell	1,345 -297	-18%	-$4.76K	﹤0.01%	6715
2019 Q1	$34K	Buy	+1,642	New	+$28.2K	﹤0.01%	5857

UBS Group's THOR Position: Q1 2020 in Review

UBS Group sold out of Synthorx, Inc. Common Stock (THOR) in Q1 2020, closing a stake of 18,056 shares — an estimated $1.26M sold.

UBS Group first reported a position in THOR in Q1 2019 and held it in 4 quarters. The position peaked at $1.26M in Q4 2019. 0 funds tracked by Wall St. Rank hold THOR as of Q1 2020.

UBS Group reported no remaining Synthorx, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
UBS Group sold 18,056 Synthorx, Inc. Common Stock shares in Q1 2020, an estimated $1.26M.
UBS Group first reported a position in Synthorx, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
UBS Group's Synthorx, Inc. Common Stock position peaked at $1.26M in Q4 2019.
0 funds tracked by Wall St. Rank held Synthorx, Inc. Common Stock as of Q1 2020.

Based on UBS Group's 13F filing for Q1 2020, filed 1 May 2020.